{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T16:45:09Z","timestamp":1782060309162,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,10]]},"DOI":"10.7759\/cureus.71187","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T09:25:33Z","timestamp":1728552333000},"source":"Crossref","is-referenced-by-count":3,"title":["Evaluating Dyslipidemia and Atherogenic Indices as Predictors of Coronary Artery Disease Risk: A Retrospective Cross-Sectional Study"],"prefix":"10.7759","author":[{"given":"Joyce  S","family":"Jose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karra","family":"Madhu Latha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna  V","family":"Bhongir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeetha","family":"Sampath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand K","family":"Pyati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096808","article-title":"Prevalence of dyslipidemia in urban and rural India: the ICMR-INDIAB study","volume":"9","author":"Joshi SR","year":"2014","unstructured":"Joshi SR, Anjana RM, Deepa M, et al.. Prevalence of dyslipidemia in urban and rural India: the ICMR-INDIAB study. PLoS One. 2014, 9:e96808. 10.1371\/journal.pone.0096808","journal-title":"PLoS One"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1140215","article-title":"The atherogenic index of plasma (AIP) is a predictor for the severity of coronary artery disease","volume":"10","author":"Li Y","year":"2023","unstructured":"Li Y, Feng Y, Li S, Ma Y, Lin J, Wan J, Zhao M. The atherogenic index of plasma (AIP) is a predictor for the severity of coronary artery disease. Front Cardiovasc Med. 2023, 10:1140215. 10.3389\/fcvm.2023.1140215","journal-title":"Front Cardiovasc Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431X20176955","article-title":"Time collection and storage conditions of lipid profile","volume":"51","author":"Fran\u00e7a CN","year":"2018","unstructured":"Fran\u00e7a CN, Mendes CC, Ferreira CE. Time collection and storage conditions of lipid profile. Braz J Med Biol Res. 2018, 51:e6955. 10.1590\/1414-431X20176955","journal-title":"Braz J Med Biol Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01990-1","article-title":"The Global Burden of Disease Study at 30 years","volume":"28","author":"Murray CJ","year":"2022","unstructured":"Murray CJ. The Global Burden of Disease Study at 30 years. Nat Med. 2022, 28:2019-26. 10.1038\/s41591-022-01990-1","journal-title":"Nat Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-021-00541-4","article-title":"Global epidemiology of dyslipidaemias","volume":"18","author":"Pirillo A","year":"2021","unstructured":"Pirillo A, Casula M, Olmastroni E, Norata GD, Catapano AL. Global epidemiology of dyslipidaemias. Nat Rev Cardiol. 2021, 18:689-700. 10.1038\/s41569-021-00541-4","journal-title":"Nat Rev Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31893-8","article-title":"Primary prevention of ischaemic heart disease: populations, individuals, and health professionals","volume":"394","author":"Gupta R","year":"2019","unstructured":"Gupta R, Wood DA. Primary prevention of ischaemic heart disease: populations, individuals, and health professionals. Lancet. 2019, 394:685-96. 10.1016\/S0140-6736(19)31893-8","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2023.11.266","article-title":"Trends in epidemiology of dyslipidemias in India","volume":"76","author":"Sharma S","year":"2024","unstructured":"Sharma S, Gaur K, Gupta R. Trends in epidemiology of dyslipidemias in India. Indian Heart J. 2024, 76:S20-8. 10.1016\/j.ihj.2023.11.266","journal-title":"Indian Heart J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008058","article-title":"The atherogenic index of plasma is a strong and independent predictor for coronary artery disease in the Chinese Han population","volume":"96","author":"Cai G","year":"2017","unstructured":"Cai G, Shi G, Xue S, Lu W. The atherogenic index of plasma is a strong and independent predictor for coronary artery disease in the Chinese Han population. Medicine (Baltimore). 2017, 96:e8058. 10.1097\/MD.0000000000008058","journal-title":"Medicine (Baltimore)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2022.07.009","article-title":"Guidelines for dyslipidemia management in India: a review of the current scenario and gaps in research","volume":"74","author":"Misra S","year":"2022","unstructured":"Misra S, Lyngdoh T, Mulchandani R. Guidelines for dyslipidemia management in India: a review of the current scenario and gaps in research. Indian Heart J. 2022, 74:341-50. 10.1016\/j.ihj.2022.07.009","journal-title":"Indian Heart J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2009.04.019","article-title":"The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries","volume":"158","author":"Teo K","year":"2009","unstructured":"Teo K, Chow CK, Vaz M, Rangarajan S, Yusuf S. The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries. Am Heart J. 2009, 158:1-7.e1. 10.1016\/j.ahj.2009.04.019","journal-title":"Am Heart J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.32231","article-title":"A descriptive study of atherogenic indices in patients admitted to a tertiary care hospital","volume":"14","author":"Dharmaraj S","year":"2022","unstructured":"Dharmaraj S, Rajaragupathy S, Denishya S. A descriptive study of atherogenic indices in patients admitted to a tertiary care hospital. Cureus. 2022, 14:e32231. 10.7759\/cureus.32231","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2023.10.023","article-title":"Comparative predictive efficacy of atherogenic indices on metabolic syndrome in patients with schizophrenia","volume":"262","author":"Tien YT","year":"2023","unstructured":"Tien YT, Wang LJ, Lee Y, Lin PY, Hung CF, Chong MY, Huang YC. Comparative predictive efficacy of atherogenic indices on metabolic syndrome in patients with schizophrenia. Schizophr Res. 2023, 262:95-101. 10.1016\/j.schres.2023.10.023","journal-title":"Schizophr Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5603\/AH.a2021.0020","article-title":"Assessment of atherogenic indices and lipid ratios in the apparently healthy women aged 30-55 years","volume":"25","author":"Gol RM","year":"2021","unstructured":"Gol RM, Rafraf M, Jafarabadi MA. Assessment of atherogenic indices and lipid ratios in the apparently healthy women aged 30-55 years. Arterial Hypertens. 2021, 25:172-7. 10.5603\/AH.a2021.0020","journal-title":"Arterial Hypertens"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference BA","year":"2017","unstructured":"Ference BA, Ginsberg HN, Graham I, et al.. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017, 38:2459-72. 10.1093\/eurheartj\/ehx144","journal-title":"Eur Heart J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2018.11.006","article-title":"Non-HDL-cholesterol and apolipoprotein B compared with LDL-cholesterol in atherosclerotic cardiovascular disease risk assessment","volume":"51","author":"Carr SS","year":"2019","unstructured":"Carr SS, Hooper AJ, Sullivan DR, Burnett JR. Non-HDL-cholesterol and apolipoprotein B compared with LDL-cholesterol in atherosclerotic cardiovascular disease risk assessment. Pathology. 2019, 51:148-54. 10.1016\/j.pathol.2018.11.006","journal-title":"Pathology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(23)00119-5","article-title":"Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17)","volume":"11","author":"Anjana RM","year":"2023","unstructured":"Anjana RM, Unnikrishnan R, Deepa M, et al.. Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17). Lancet Diabetes Endocrinol. 2023, 11:474-89. 10.1016\/S2213-8587(23)00119-5","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald WT","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972, 18:499-502.","journal-title":"Clin Chem"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)","volume":"285","year":"2001","unstructured":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001, 285.2486-97. 10.1001\/jama.285.19.2486","journal-title":"JAMA"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4782344","article-title":"Dyslipidemia diagnosis and treatment: risk stratification in children and adolescents","volume":"2022","author":"Mosca S","year":"2022","unstructured":"Mosca S, Ara\u00fajo G, Costa V, et al.. Dyslipidemia diagnosis and treatment: risk stratification in children and adolescents. J Nutr Metab. 2022, 2022:4782344. 10.1155\/2022\/4782344","journal-title":"J Nutr Metab"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0000000000000754","article-title":"Update on apolipoprotein B","volume":"32","author":"Sniderman A","year":"2021","unstructured":"Sniderman A, Langlois M, Cobbaert C. Update on apolipoprotein B. Curr Opin Lipidol. 2021, 32:226-30. 10.1097\/MOL.0000000000000754","journal-title":"Curr Opin Lipidol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32519-X","article-title":"Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium","volume":"394","author":"Brunner FJ","year":"2019","unstructured":"Brunner FJ, Waldeyer C, Ojeda F, et al.. Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium. Lancet. 2019, 394:2173-83. 10.1016\/S0140-6736(19)32519-X","journal-title":"Lancet"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz785","article-title":"Clinical review on triglycerides","volume":"41","author":"Laufs U","year":"2020","unstructured":"Laufs U, Parhofer KG, Ginsberg HN, Hegele RA. Clinical review on triglycerides. Eur Heart J. 2020, 41:99-109c. 10.1093\/eurheartj\/ehz785","journal-title":"Eur Heart J"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2017.02.020","article-title":"Recent trends in epidemiology of dyslipidemias in India","volume":"69","author":"Gupta R","year":"2017","unstructured":"Gupta R, Rao RS, Misra A, Sharma SK. Recent trends in epidemiology of dyslipidemias in India. Indian Heart J. 2017, 69:382-92. 10.1016\/j.ihj.2017.02.020","journal-title":"Indian Heart J"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000580","article-title":"Atherosclerotic cardiovascular disease in South Asians in the United States: epidemiology, risk factors, and treatments: a scientific statement from the American Heart Association","volume":"138","author":"Volgman AS","year":"2018","unstructured":"Volgman AS, Palaniappan LS, Aggarwal NT, et al.. Atherosclerotic cardiovascular disease in South Asians in the United States: epidemiology, risk factors, and treatments: a scientific statement from the American Heart Association. Circulation. 2018, 138:e1-34. 10.1161\/CIR.0000000000000580","journal-title":"Circulation"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62038-7","article-title":"National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3\u00b70 million participants","volume":"377","author":"Farzadfar F","year":"2011","unstructured":"Farzadfar F, Finucane MM, Danaei G, et al.. National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3\u00b70 million participants. Lancet. 2011, 377:578-86. 10.1016\/S0140-6736(10)62038-7","journal-title":"Lancet"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(19)30003-8","article-title":"Rethinking good cholesterol: a clinicians' guide to understanding HDL","volume":"7","author":"Xiang AS","year":"2019","unstructured":"Xiang AS, Kingwell BA. Rethinking good cholesterol: a clinicians' guide to understanding HDL. Lancet Diabetes Endocrinol. 2019, 7:575-82. 10.1016\/S2213-8587(19)30003-8","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref27","article-title":"Atherogenic index of plasma (AIP): a marker of cardiovascular disease","volume":"29","author":"Niroumand S","year":"2015","unstructured":"Niroumand S, Khajedaluee M, Khadem-Rezaiyan M, et al.. Atherogenic index of plasma (AIP): a marker of cardiovascular disease. Med J Islam Repub Iran. 2015, 29:240.","journal-title":"Med J Islam Repub Iran"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2014.03.005","article-title":"Cholesterol lipoproteins and prevalence of dyslipidemias in urban Asian Indians: a cross sectional study","volume":"66","author":"Guptha S","year":"2014","unstructured":"Guptha S, Gupta R, Deedwania P, et al.. Cholesterol lipoproteins and prevalence of dyslipidemias in urban Asian Indians: a cross sectional study. Indian Heart J. 2014, 66:280-8. 10.1016\/j.ihj.2014.03.005","journal-title":"Indian Heart J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/296374-evaluating-dyslipidemia-and-atherogenic-indices-as-predictors-of-coronary-artery-disease-risk-a-retrospective-cross-sectional-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T09:25:36Z","timestamp":1728552336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/296374-evaluating-dyslipidemia-and-atherogenic-indices-as-predictors-of-coronary-artery-disease-risk-a-retrospective-cross-sectional-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,10]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.71187","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,10]]}}}